0B1 (Oxybutynin Chloride Extended-Release 5 mg)
Pill with imprint 0B1 is Yellow, Round and has been identified as Oxybutynin Chloride Extended-Release 5 mg. It is supplied by Ajanta Pharma Limited.
Oxybutynin is used in the treatment of urinary incontinence; urinary frequency; dysuria; neurogenic detrusor overactivity and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 0B1
Oxybutynin Chloride Extended-Release
- Imprint
- 0B1
- Strength
- 5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ajanta Pharma Limited
- National Drug Code (NDC)
- 27241-0155
Related Images for "0B1"
More about oxybutynin
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 379 Reviews
- Drug class: urinary antispasmodics
- FDA Alerts (1)
Consumer resources
- Patient Information
- Oxybutynin transdermal
- Oxybutynin (Advanced Reading)
- Oxybutynin Transdermal (Advanced Reading)
- Oxybutynin Extended-Release Tablets
- ... +4 more
- Other brands
- Ditropan, Ditropan XL, Oxytrol, Gelnique, Anturol
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.